Human Immunodeficiency Virus Type 1 Vpu Inhibitor, BIT225, in Combination with 3-Drug Antiretroviral Therapy: Inflammation and Immune Cell Modulation

Carolyn A. Luscombe*, Anchalee Avihingsanon, Khuanchai Supparatpinyo, Sivaporn Gatechompol, Win Min Han, Gary D. Ewart, Audrey S. Thomson, Michelle Miller, Stephen Becker, Robert L. Murphy

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Human Immunodeficiency Virus Type 1 Vpu Inhibitor, BIT225, in Combination with 3-Drug Antiretroviral Therapy: Inflammation and Immune Cell Modulation'. Together they form a unique fingerprint.

Immunology and Microbiology

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science